Quantcast
Last updated on April 23, 2014 at 13:36 EDT

Latest Bisoprolol Stories

2012-05-14 10:00:48

A new study has found that, contrary to current thinking, taking beta blockers that treat high blood pressure does not decrease a person's risk of developing colorectal cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also revealed that even long-term use or subtypes of beta blockers showed no reduction of colorectal cancer risk. In recent years, researchers have thought that beta blockers, which are prescribed to many older adults...

2011-08-16 12:29:11

A comparison of several international clinical trials of beta-blocker drugs has shown there are notable differences in how well the drugs prevent deaths in heart failure patients, based on where the patients were treated. In this study, U.S. patients apparently had a lower survival rate with beta-blocker treatment compared to patients outside the U.S. The analysis is published online today in the Journal of the American College of Cardiology. "Our analysis showed the survival rate associated...

2010-02-10 11:15:09

Future studies using universal methods may give physicians clear answers about who should get beta blockers and at what dosage In a commentary appearing in this week's Journal of the American Medical Association, heart specialists at the University of Michigan Health System make a plea for clarity on the best approach for prescribing beta blockers before surgery. It's not unusual for patients to suffer a cardiac event during surgery, and in theory, beta blockers will reduce the risk by...

2009-11-20 15:46:45

In a new study, researchers report that a class of heart medications called beta-blockers can have a helpful, or harmful, effect on the heart, depending on their molecular activity. The study, which appears in the journal Circulation Research, found that beta-blockers that target both the alpha- and beta-receptors on the heart muscle offer the most benefit to cardiac patients, while those that target only the beta-receptors can actually undermine the structure and function of the heart....

2009-11-17 07:00:00

Study highlights: -- Although many studies have shown that beta blockers improve outcomes for heart failure patients, the optimum dose is still unknown. -- A new Japanese study finds the smallest dose of beta blockers is as effective as larger ones, with fewer side effects. ORLANDO, Fla., Nov. 17 /PRNewswire-USNewswire/ -- Tailoring the dose of a heart failure drug to a patient's response is better than the one-size-fits-all approach, according to research presented in a late-breaking...

2009-05-31 10:06:21

Results and updates from eight studies were presented during a late-breaking trials session at Heart Failure 2009. Reviewing them at a press conference, Professor John McMurray, President of the Heart Failure Association, described the trials' objectives and main implications. A multicenter study of a new inotropic drug (which increases the contraction and pumping of the heart), CK-1827452, found that it increases systolic function in stable heart failure patients "“ and was well...

2008-03-25 15:07:02

Beta-blockers heal the heart via the brain when administered during heart failure, according to a new study by UCL (University College London). Up to now, it was thought that beta-blockers work directly on the heart, but the new study shows that the drugs may also act via the brain, suggesting that future therapies to treat cardiovascular disease could be targeting the central nervous system.Heart failure patients are routinely given beta-blockers, although doctors do not know exactly how...